NCT04827407 - Lipopolysaccharide Adsorption At Septic Shock | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 23, 2021

Primary Completion Date

March 30, 2022

Study Completion Date

August 30, 2022

Conditions

Septic Shock

Interventions

DEVICE

Efferon LPS hemoperfusion

Hemoperfusion using continuous extracorporeal LPS adsorption with Efferon LPS therapeutic device during a period of 24h immediately following admission to the intensive care unit

Trial Locations (4)

109263

V.P. Demikhov City Clinical Hospital No. 68, Moscow

Unknown

N.I. Pirogov City Clinical Hospital No. 1, Moscow

N.V. Sklifosovsky Moscow Research Institute of Emergency, Moscow

S.S. Yudin City Clinical Hospital, Moscow